Anhui Nature Pharma is a National High-Tech Enterprise of China established in December 2016 with total investment of 150 million yuan. We have R&D centers in Anqing and Hefei cities with a total area of about 6500 ㎡, 100 hoods, and 10 pilot labs(20*100L reactors), equipped with HPLC, GC, LC-MS and other important inspection equipments. We also have wholly-owned manufacture plant in Anqing National High-tech Industrial Development Zone, a National Chemical Industry Park.It covers an area of 28000 ㎡, with two workshops and total capacity could reach 150m3. Our team consists of members with more than 10 years of experience working in world leading CRO/CMO companies. Its mainly products includes API intermediates such as Ticagrelor, Ibrutinib, Elagolix sodium, Roxadustat, etc and novel building blocks We focus on process development and manufacture of RSM and advanced intermediates for small molecule drugs, and provide corresponding CDMO services.From mg to ton, we strive to accelerate your new drug R&D！